machinetranslation
Bird Flu Vaccine Production in Indonesia Ready Next Year
Author: Cornelius Eko Susanto
Wednesday, January 25, 2012
JAKARTA - MICOM: Health Minister Endang Rahayu Sedyaningsih proclaimed Indonesia will be able to produce the H5N1 virus vaccine in 2013. It was launched after PT Bio Farma to get a prototype bird flu vaccine from the University of Indonesia (UI) and University Press. "expected by the end of 2013 the final vaccine avian influenza (AI) can already be mass produced by Bio Farma.
The road to produce H5N1 vaccine itself is long because must undergo clinical trials process several times, "said Minister of Health, after the signing of the Memorandum of Understanding on the Synergy Research and Development of Vaccines and Drug Raw Materials, Wednesday (25 / 1), in Jakarta. The delivery of a prototype vaccine was vetted UI at the event.
Meanwhile, the prototype vaccine from Unair been submitted at some earlier time. Minister of Health explain Kemenkes has awarded seed (seed) H5N1 vaccine to the country's second university to be made a prototype vaccine. He explained Unair create a prototype vaccine using reverse genetics.
Meanwhile, the UI using the method of DNA vaccine. president director of PT Bio Farma (Persero) Iskandar stated penyerahah AI prototype vaccine is the initial support order perseroannya government can realize the acceleration of vaccine research.
In normal time, research and development of vaccine research from the beginning to the end of the process takes time about 15 years. Considering the length of time it takes, then go Iskandar, it takes a short cut to accelerate vaccine research. "Short cut is needed is a synergy between the academic, business and government," he said.
The synergy between the academic, business, and Government (ABG) done PT Bio Farma lead to the re-establishment of the National Vaccine Research Forum (FRVN). FVRN is an advanced program of the National Vaccine Research Symposium Independence in the past year. The symposium resulted in eight consortium for research and development of future vaccine research. (Tlc/OL-10)
Media Indonesia
Bird Flu Vaccine Production in Indonesia Ready Next Year
Author: Cornelius Eko Susanto
Wednesday, January 25, 2012
JAKARTA - MICOM: Health Minister Endang Rahayu Sedyaningsih proclaimed Indonesia will be able to produce the H5N1 virus vaccine in 2013. It was launched after PT Bio Farma to get a prototype bird flu vaccine from the University of Indonesia (UI) and University Press. "expected by the end of 2013 the final vaccine avian influenza (AI) can already be mass produced by Bio Farma.
The road to produce H5N1 vaccine itself is long because must undergo clinical trials process several times, "said Minister of Health, after the signing of the Memorandum of Understanding on the Synergy Research and Development of Vaccines and Drug Raw Materials, Wednesday (25 / 1), in Jakarta. The delivery of a prototype vaccine was vetted UI at the event.
Meanwhile, the prototype vaccine from Unair been submitted at some earlier time. Minister of Health explain Kemenkes has awarded seed (seed) H5N1 vaccine to the country's second university to be made a prototype vaccine. He explained Unair create a prototype vaccine using reverse genetics.
Meanwhile, the UI using the method of DNA vaccine. president director of PT Bio Farma (Persero) Iskandar stated penyerahah AI prototype vaccine is the initial support order perseroannya government can realize the acceleration of vaccine research.
In normal time, research and development of vaccine research from the beginning to the end of the process takes time about 15 years. Considering the length of time it takes, then go Iskandar, it takes a short cut to accelerate vaccine research. "Short cut is needed is a synergy between the academic, business and government," he said.
The synergy between the academic, business, and Government (ABG) done PT Bio Farma lead to the re-establishment of the National Vaccine Research Forum (FRVN). FVRN is an advanced program of the National Vaccine Research Symposium Independence in the past year. The symposium resulted in eight consortium for research and development of future vaccine research. (Tlc/OL-10)
Media Indonesia
Comment